Common Contracts
4 similar Placement Agent Agreement contracts by Bio-Path Holdings Inc, Fresh Medical Laboratories, Inc., Prolung Inc
FRESH MEDICAL LABORATORIES, INC. PLACEMENT AGENT AGREEMENT December 28, 2015 ACAP Financial, Inc. Salt Lake City, Utah 84101 Attn: Mr. Kirk Ferguson Gentlemen:Placement Agent Agreement • May 5th, 2020 • Utah
Fresh Medical Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to qualified investors in a private placement an aggregate of a maximum of 3,500,000 shares and a minimum of 333,333 shares of the Company’s common stock (the “Shares”), at a price of $1.50 per Share ($5,250,000 maximum and $500,000 minimum).
FRESH MEDICAL LABORATORIES, INC. PLACEMENT AGENT AGREEMENT March 6, 2017Placement Agent Agreement • May 22nd, 2017 • Prolung Inc • Surgical & medical instruments & apparatus • Utah
Fresh Medical Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to qualified investors in a private placement shares of the Company’s common stock (the “Shares”), at a price of $1.50 per Share.
FRESH MEDICAL LABORATORIES, INC. PLACEMENT AGENT AGREEMENT December 28, 2015Placement Agent Agreement • April 14th, 2016 • Fresh Medical Laboratories, Inc. • Surgical & medical instruments & apparatus • Utah
Fresh Medical Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to qualified investors in a private placement an aggregate of a maximum of 3,500,000 shares and a minimum of 333,333 shares of the Company’s common stock (the “Shares”), at a price of $1.50 per Share ($5,250,000 maximum and $500,000 minimum).
BIO-PATH HOLDINGS, INC. PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • April 1st, 2013 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • Utah
Bio-Path Holdings, Inc., a Utah corporation (the “Company”), proposes to sell to qualified investors in a private placement an aggregate of up to $2,000,000 of Common Stock, no par value, at a price of $0.30 per share (the “Shares”). The offering of the Shares (the “Offering”) shall be on a “best efforts” basis. The Shares are further described in the Confidential Private Placement Memorandum dated on or about April 13, 2012 (the “Memorandum”) prepared for use in connection with the Offering. The business to be conducted by the Company and the Offering are each more fully described in the Memorandum. Certain terms not otherwise defined in this Placement Agent Agreement (the “Agreement”) shall have the same meanings as given to them in the Memorandum. The term Memorandum includes all appendices and exhibits attached thereto, as well as any supplements, or amendments to the Memorandum.
